NCT05534516
A Study of Physiologic Changes in a Telemetry Unit
Enrolling by Invitation
Not specifiedAges 18–65ObservationalMayo ClinicInvestigator-initiated
~500 participants
Updated 2025-10-01 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Heart Rate
Measured over Baseline, through telemetry unit stay (approximately 1-3 days)
+4 more outcomes measured
Conditions
Where it's being run
1 sites across 1 statesFlorida1
Study leadership
- Antonio Forte, MD, PhD · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Admitted to telemetry unit
With acute illness
Received any type of medication via any route of administration (oral, sublingual, intranasal, inhalational, intramuscular, intravenous, subcutaneous, transdermal)
Received any amount of any type of intravenous fluids
Cognitively and/or physically be able to sign consent
What this trial measures
- Change in Heart RateBaseline, through telemetry unit stay (approximately 1-3 days)
Number of beats per minute
- Change in Blood PressureBaseline, through telemetry unit stay (approximately 1-3 days)
Measured in millimeters of mercury (mmHg)
- Change in Respiratory RateBaseline, through telemetry unit stay (approximately 1-3 days)
Number of breaths per minute
- Change in Oxygen Saturation LevelsBaseline, through telemetry unit stay (approximately 1-3 days)
Measured by a pulse oximeter reading reported as a percentage
- Change in ECG morphologyBaseline, through telemetry unit stay (approximately 1-3 days)
Changes in ECG waveform appearance measured from the digital ECG waveform interpretation